• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What Can Payers Do to Improve Biosimilar Uptake? Ryan Haumschild, PharmD, Weighs In

Video

Ryan Haumschild, PharmD, MS, MBA, director of pharmacy services at Emory Healthcare and Winship Cancer Institute, explains how payers can play an essential role in improving biosimilar adoption.

Ryan Haumschild, PharmD, MS, MBA, director of pharmacy services at Emory Healthcare and Winship Cancer Institute, explains how payers can play an essential role in improving biosimilar adoption at the Academy of Managed Care Pharmacy's annual meeting in Chicago, Illinois.

Transcript:

What more should payers being doing to improve biosimilar uptake and adoption?

Haumschild: Our payer colleagues are so essential to what we do and I think they understand the value of biosimilars. And I think the more you can leverage biosimilars as a preferred agent by the plan, you can reduce total cost of care, you can create some flexibility to health care providers to choose the best biosimilar for them, as long as they know a biosimilar is going to be the preferred treatment, and then continue to leverage real world evidence of biosimilar use so we can continue to expand that rollout across many different practice settings.

Related Videos
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.